QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InMed Pharmaceuticals Inc. stock logo
IN
InMed Pharmaceuticals
C$4.19
C$3.35
C$13.86
C$33.73MN/A29,552 shs17,035 shs
Inventronics Limited stock logo
IVX
Inventronics
C$0.75
-7.4%
C$0.87
C$0.64
C$3.80
C$3.65M0.835,360 shs2,353 shs
Meredith Co. stock logo
MDP
Meredith
$58.78
$18.00
$59.16
$2.70B2.07552,848 shs3.36 million shs
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
C$0.00
C$0.03
C$0.64
N/AN/A79,508 shs287,225 shs
Savaria Co. stock logo
SIS
Savaria
C$16.70
+0.4%
C$16.64
C$12.21
C$17.70
C$1.18B0.8559,792 shs80,778 shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InMed Pharmaceuticals Inc. stock logo
IN
InMed Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
Inventronics Limited stock logo
IVX
Inventronics
-7.41%-1.32%-8.54%-21.05%-80.26%
Meredith Co. stock logo
MDP
Meredith
0.00%0.00%0.00%0.00%-16.22%
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
0.00%0.00%0.00%0.00%0.00%
Savaria Co. stock logo
SIS
Savaria
-0.48%-0.54%-1.42%+9.26%+2.46%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
InMed Pharmaceuticals Inc. stock logo
IN
InMed Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Inventronics Limited stock logo
IVX
Inventronics
N/AN/AN/AN/AN/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/AN/AN/AN/AN/A
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/AN/AN/AN/AN/AN/A
Savaria Co. stock logo
SIS
Savaria
3.5044 of 5 stars
4.50.00.80.03.20.81.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InMed Pharmaceuticals Inc. stock logo
IN
InMed Pharmaceuticals
N/AN/AN/AN/A
Inventronics Limited stock logo
IVX
Inventronics
N/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/A
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/AN/A
Savaria Co. stock logo
SIS
Savaria
3.00
BuyC$21.6429.60% Upside

Current Analyst Ratings

Latest MDP, IN, MMJ, SIS, and IVX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/12/2024
Savaria Co. stock logo
SIS
Savaria
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuyC$21.00 ➝ C$23.00
4/10/2024
Savaria Co. stock logo
SIS
Savaria
Desjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuyC$22.50 ➝ C$23.50
3/8/2024
Savaria Co. stock logo
SIS
Savaria
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$17.00 ➝ C$21.50
3/8/2024
Savaria Co. stock logo
SIS
Savaria
Desjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuyC$20.50 ➝ C$22.50
3/8/2024
Savaria Co. stock logo
SIS
Savaria
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuyC$25.00 ➝ C$23.00
3/8/2024
Savaria Co. stock logo
SIS
Savaria
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$18.00 ➝ C$19.00
3/8/2024
Savaria Co. stock logo
SIS
Savaria
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuyC$20.00 ➝ C$21.00
3/8/2024
Savaria Co. stock logo
SIS
Savaria
Cormark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$18.00 ➝ C$21.00
3/7/2024
Savaria Co. stock logo
SIS
Savaria
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$19.50 ➝ C$20.50
2/12/2024
Savaria Co. stock logo
SIS
Savaria
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuyC$18.00 ➝ C$20.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InMed Pharmaceuticals Inc. stock logo
IN
InMed Pharmaceuticals
C$574.68K0.00N/A10.40C$0.76 per share0.00
Inventronics Limited stock logo
IVX
Inventronics
C$10.77M0.34C$0.09 per share8.81C$0.62 per share1.21
Meredith Co. stock logo
MDP
Meredith
$2.98B0.00N/A5.68$14.27 per share0.00
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/AN/AN/AN/A
Savaria Co. stock logo
SIS
Savaria
C$836.95M1.42C$0.92 per share18.13C$7.74 per share2.16

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InMed Pharmaceuticals Inc. stock logo
IN
InMed Pharmaceuticals
N/A-C$1.51N/AN/AN/AN/AN/AN/AN/A
Inventronics Limited stock logo
IVX
Inventronics
C$1.46MC$0.164.69N/A7.69%29.68%12.00%4/25/2024 (Estimated)
Meredith Co. stock logo
MDP
Meredith
$306.60M$5.9010.01N/AN/A9.66%41.72%4.92%N/A
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Savaria Co. stock logo
SIS
Savaria
C$37.84MC$0.5729.3042.724.52%7.55%4.46%5/8/2024 (Estimated)

Latest MDP, IN, MMJ, SIS, and IVX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
Inventronics Limited stock logo
IVX
Inventronics
N/A-C$0.04-C$0.04-C$0.04N/AC$0.96 million
3/6/2024Q4 2023
Savaria Co. stock logo
SIS
Savaria
C$0.18C$0.19+C$0.01C$0.22C$214.78 millionC$216.84 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
InMed Pharmaceuticals Inc. stock logo
IN
InMed Pharmaceuticals
N/AN/AN/AN/AN/A
Inventronics Limited stock logo
IVX
Inventronics
C$0.3546.67%N/A218.75%N/A
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/AN/A
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/AN/AN/A
Savaria Co. stock logo
SIS
Savaria
C$0.523.11%N/A91.23%N/A

Latest MDP, IN, MMJ, SIS, and IVX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/21/2024
Savaria Co. stock logo
SIS
Savaria
MonthlyC$0.043.07%3/27/20243/28/20244/10/2024
2/16/2024
Savaria Co. stock logo
SIS
Savaria
MonthlyC$0.043.09%2/28/20242/29/20243/8/2024
1/24/2024
Savaria Co. stock logo
SIS
Savaria
MonthlyC$0.043.26%1/30/20241/31/20242/9/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InMed Pharmaceuticals Inc. stock logo
IN
InMed Pharmaceuticals
8.48
2.13
1.45
Inventronics Limited stock logo
IVX
Inventronics
88.43
3.80
1.06
Meredith Co. stock logo
MDP
Meredith
4.03
1.39
1.36
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/A
Savaria Co. stock logo
SIS
Savaria
58.17
1.98
0.91

Ownership

Institutional Ownership

CompanyInstitutional Ownership
InMed Pharmaceuticals Inc. stock logo
IN
InMed Pharmaceuticals
N/A
Inventronics Limited stock logo
IVX
Inventronics
N/A
Meredith Co. stock logo
MDP
Meredith
78.23%
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/A
Savaria Co. stock logo
SIS
Savaria
28.02%

Insider Ownership

CompanyInsider Ownership
InMed Pharmaceuticals Inc. stock logo
IN
InMed Pharmaceuticals
N/A
Inventronics Limited stock logo
IVX
Inventronics
69.96%
Meredith Co. stock logo
MDP
Meredith
9.79%
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/A
Savaria Co. stock logo
SIS
Savaria
19.86%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
InMed Pharmaceuticals Inc. stock logo
IN
InMed Pharmaceuticals
128.05 millionN/ANot Optionable
Inventronics Limited stock logo
IVX
Inventronics
N/A4.87 millionN/ANot Optionable
Meredith Co. stock logo
MDP
Meredith
5,33045.78 million41.30 millionOptionable
Matica Enterprises Inc stock logo
MMJ
Matica Enterprises
N/AN/AN/ANot Optionable
Savaria Co. stock logo
SIS
Savaria
2,45070.94 millionN/ANot Optionable

MDP, IN, MMJ, SIS, and IVX Headlines

SourceHeadline
Savaria Publishes Its First Environmental, Social and Governance ReportSavaria Publishes Its First Environmental, Social and Governance Report
finance.yahoo.com - April 17 at 1:32 PM
Cormark Comments on Savaria Co.s FY2024 Earnings (TSE:SIS)Cormark Comments on Savaria Co.'s FY2024 Earnings (TSE:SIS)
americanbankingnews.com - April 15 at 1:34 AM
TD Securities Boosts Savaria (TSE:SIS) Price Target to C$23.00TD Securities Boosts Savaria (TSE:SIS) Price Target to C$23.00
americanbankingnews.com - April 14 at 3:02 AM
Cormark Weighs in on Savaria Co.s FY2025 Earnings (TSE:SIS)Cormark Weighs in on Savaria Co.'s FY2025 Earnings (TSE:SIS)
americanbankingnews.com - April 13 at 3:06 AM
Q2 2024 Earnings Estimate for Savaria Co. (TSE:SIS) Issued By DesjardinsQ2 2024 Earnings Estimate for Savaria Co. (TSE:SIS) Issued By Desjardins
americanbankingnews.com - April 13 at 2:16 AM
Savaria (TSE:SIS) Price Target Increased to C$23.00 by Analysts at TD SecuritiesSavaria (TSE:SIS) Price Target Increased to C$23.00 by Analysts at TD Securities
marketbeat.com - April 12 at 2:26 PM
Equities Analysts Offer Predictions for Savaria Co.s FY2025 Earnings (TSE:SIS)Equities Analysts Offer Predictions for Savaria Co.'s FY2025 Earnings (TSE:SIS)
marketbeat.com - April 12 at 6:40 AM
Q3 2024 EPS Estimates for Savaria Co. Boosted by Analyst (TSE:SIS)Q3 2024 EPS Estimates for Savaria Co. Boosted by Analyst (TSE:SIS)
americanbankingnews.com - April 12 at 1:36 AM
Q3 2024 EPS Estimates for Savaria Co. (TSE:SIS) Lifted by DesjardinsQ3 2024 EPS Estimates for Savaria Co. (TSE:SIS) Lifted by Desjardins
marketbeat.com - April 11 at 7:26 AM
Desjardins Increases Savaria (TSE:SIS) Price Target to C$23.50Desjardins Increases Savaria (TSE:SIS) Price Target to C$23.50
americanbankingnews.com - April 11 at 3:52 AM
Savaria - The Only Way Is UpSavaria - The Only Way Is Up
seekingalpha.com - April 10 at 7:29 PM
Savaria (TSE:SIS) Price Target Raised to C$23.50 at DesjardinsSavaria (TSE:SIS) Price Target Raised to C$23.50 at Desjardins
marketbeat.com - April 10 at 2:06 PM
Savaria (TSE:SIS) Stock Price Crosses Above Fifty Day Moving Average of $16.56Savaria (TSE:SIS) Stock Price Crosses Above Fifty Day Moving Average of $16.56
americanbankingnews.com - April 9 at 4:42 AM
Savaria (TSE:SIS) Share Price Crosses Above Fifty Day Moving Average of $16.56Savaria (TSE:SIS) Share Price Crosses Above Fifty Day Moving Average of $16.56
marketbeat.com - April 9 at 4:40 AM
Savaria Co. (TSE:SIS) Given Average Rating of "Buy" by BrokeragesSavaria Co. (TSE:SIS) Given Average Rating of "Buy" by Brokerages
marketbeat.com - April 1 at 4:14 AM
Savaria: Long-Term Tailwinds And Insider BuyingSavaria: Long-Term Tailwinds And Insider Buying
seekingalpha.com - April 1 at 2:33 AM
Savaria Co. Declares Monthly Dividend of $0.04 (TSE:SIS)Savaria Co. Declares Monthly Dividend of $0.04 (TSE:SIS)
marketbeat.com - March 22 at 8:52 AM
Monthly Money-Makers: 3 Dividend Stocks Paying Cash RegularlyMonthly Money-Makers: 3 Dividend Stocks Paying Cash Regularly
msn.com - March 21 at 9:10 PM
SIS:CA Stock PriceSIS:CA Stock Price
seekingalpha.com - March 21 at 4:09 PM
Thursday’s Insider Report: Chairman invests $1-million in this dividend stock with a unanimous buy call from seven analystsThursday’s Insider Report: Chairman invests $1-million in this dividend stock with a unanimous buy call from seven analysts
theglobeandmail.com - March 14 at 9:23 AM
All About Ryan Goslings Sister, Mandi GoslingAll About Ryan Gosling's Sister, Mandi Gosling
people.com - March 14 at 12:35 AM
My entitled sister-in-law stole our baby name - I made her regret it'My entitled sister-in-law stole our baby name - I made her regret it'
mirror.co.uk - March 14 at 12:35 AM
Savaria Corporation (SISXF) Q4 2023 Earnings Call TranscriptSavaria Corporation (SISXF) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 9 at 1:08 PM
Savaria Full Year 2023 Earnings: EPS Misses ExpectationsSavaria Full Year 2023 Earnings: EPS Misses Expectations
finance.yahoo.com - March 8 at 7:48 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

InMed Pharmaceuticals logo

InMed Pharmaceuticals

TSE:IN
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
Inventronics logo

Inventronics

CVE:IVX
Inventronics Limited designs, manufactures, and sells protective enclosures and related products for the telecommunications, cable, electric transmission, oil and gas, and other industries in North America. The company offers CP Pedestal series for CATV distribution equipment; IVT BOBCAT co-locate cabinet series for broadband node locations supporting remote deployment of network electronics, including power supply, batteries, and RF components; SG pedestals for utility and communication industries; and MDU enclosure series for cable and telecom companies. It also provides Nema 4/4x enclosures for wall-mount, pole-mount, and free-standing enclosures with one door; Nema 4/4x cabinets for control gateways or data rooms; and Nema 1/12 cabinets and enclosures for use in data and electronic control applications. In addition, it offers M/U pedestal series for power/cable TV/telecom subsurface-to-ground access; residential, commercial, and industrial enclosures for new and existing developments; urban and rural locations; termination, splicing, and loading of buried wire and cable; and secondary junction boxes/pedestals. Further, the company provides FDE enclosures designed for fiber optic splicing, as well as organization, splicing, and security for FTTx, broadband, distribution, and building entrance applications; traffic control enclosures for traffic control equipment; and urban refuse and recycling bins, such as single refuse and recycle bins, single dog bag dispensers, refuse/dog dispenser combos, refuse/recycling bin combos, and refuse/recycling/dog dispenser combos. Inventronics Limited was founded in 1970 and is based in Brandon, Canada.
Meredith logo

Meredith

NYSE:MDP
Meredith Corp. engages in television broadcasting and magazine advertising business. It operates through the Local Media and National Media business segments. The Local Media segment includes television stations and offers websites, mobile-optimized websites, and mobile applications. The National Media segment consists of national consumer media brands delivered via multiple media platforms including print magazines and digital and mobile media, brand licensing activities, database-related activities, and business-to-business marketing products and services. The company was founded by Edwin Thomas Meredith in 1902 and is headquartered in Des Moines, IA.
Matica Enterprises logo

Matica Enterprises

CNSX:MMJ
Matica Enterprises Inc. focuses on medical marijuana business. It also holds interest in the Grumpy Lizard project in Nevada, the United States; and an option agreement to acquire a 100% interest in the Buckingham North property, a graphite project located east of Ottawa/Gatineau. The company was formerly known as Matica Graphite Inc. and changed its name to Matica Enterprises Inc. in July 2014. Matica Enterprises Inc. is headquartered in Toronto, Canada.
Savaria logo

Savaria

TSE:SIS
Savaria Corporation provides accessibility solutions for the elderly and physically challenged people in Canada, the United States, Europe, and internationally. The company operates in two segments, Accessibility and Patient Care. The Accessibility segment designs, manufactures, distributes, and installs a portfolio of accessibility products, including commercial and home elevators, stairlifts, platform lifts, and wheelchair lowered-floor accessible conversions for selected brands of minivans, personal, residential, or commercial applications. The Patient Care segment designs, manufactures, distributes, and installs ceiling lifts, patient transfer slings and accessories, floor lifts, standing aids, bathing equipment, medical beds, therapeutic support surfaces, and pressure management products used in healthcare facilities and home care settings. It sells its products through dealers or direct stores to end-user customers. The company was founded in 1979 and is headquartered in Laval, Canada.